iso-Migrastatin and related glutarimide-containing polyketides are potent inhibitors of tumor cell migration and their implied potential as antimetastatic agents for human cancers has garnered significant attention. Genome scanning of Streptomyces platensis NRRL 18993 unveiled two candidate gene clusters (088D and mgs); each encodes acyltransferase-less type I polyketide synthases commensurate with iso-migrastatin biosynthesis. Both clusters were inactivated by -RED-mediated PCR-targeting mutagenesis in S. platensis; iso-migrastatin production was completely abolished in the ⌬mgsF mutant SB11012 strain, whereas inactivation of 088D-orf7 yielded the SB11006 strain that exhibited no discernible change in iso-migrastatin biosynthesis. These data indicate that iso-migrastatin production is governed by the mgs cluster. Systematic gene inactivation allowed determination of the precise boundaries of the mgs cluster and the essentiality of the genes within the mgs cluster in iso-migrastatin production. The mgs cluster consists of 11 open reading frames that encode three acyltransferase-less type I polyketide synthases (MgsEFG), one discrete acyltransferase (MgsH), a type II thioesterase (MgsB), three post-PKS tailoring enzymes (MgsIJK), two glutarimide biosynthesis enzymes (MgsCD), and one regulatory protein (MgsA). A model for isomigrastatin biosynthesis is proposed based on functional assignments derived from bioinformatics and is further supported by the results of in vivo gene inactivation experiments.
timidomycin (LTM) (Fig. 1 ) are potent inhibitors of human tumor cell migration and thus represent novel leads for anticancer drug discovery (2) (3) (4) (5) . Synthetic analogs of these natural products have also been investigated and found to retain potent activity despite significant structural truncation (6 -8) . Retention of activity by such analogs supports the effectiveness of the privileged scaffolds highlighted by iso-MGS, MGS, LTM, and related natural products. Complementary to organic synthesis, combinatorial biosynthesis offers an alternative means of accessing natural product structural diversity. We have previously studied the biosynthetic pathway of these polyketides and shown that MGS and the DGNs are shunt metabolites of iso-MGS (9) . As has been demonstrated in Streptomyces platensis NRRL 18993, one of the known iso-MGS producers, iso-MGS, MGS, and the DGNs are produced by a single biosynthetic machinery and iso-MGS undergoes H 2 O-mediated, non-enzymatic ring-expansion, and ring-opening rearrangements to afford MGS and the DGNs as shunt metabolites. We have also isolated iso-MGS congeners as minor fermentation products, produced a small library of glutarimide-containing polyketides featuring the iso-MGS, LTM, MGS, and DGN scaffolds, and found selected analogs with biological activity to far surpass those of MGS (10 -14) . In so doing, we have shown the general superiority of 12-membered macrolides over the 14-membered analogs as glutarimide-containing polyketide inhibitors of cell migration. Yet, the ability to readily convert members of the 12-membered macrolides into their corresponding 14-membered and acyclic congeners synthetically presents us with novel structural diversity capabilities not commonly encountered biosynthetically. Cloning and characterization of the gene cluster governing iso-MGS biosynthesis, therefore, represents a significant undertaking with many foreseeable ramifications in drug discovery.
Here we report: (i) development of a genetic system for S. platensis NRRL 18993, (ii) identification and cloning of two acyltransferase (AT)-less type I polyketide synthase (PKS)-encoding clusters (088D and mgs) in S. platensis NRRL 18993 along with assignment of one (088D) as a cryptic cluster and the other (mgs) as being exclusively accountable for iso-MGS, thereby MGS and DGN, biosynthesis, and (iii) an experimentally supported proposal for a single biosynthesis machinery governing the production of iso-MGS, MGS, and the DGNs.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, and Culture Conditions-Escherichia coli DH5␣ (15) , ET12567 (16) , BW25113 (16) strains were cultured in Luria-Bertani medium (15) . S. platensis NRRL 18993 wild-type (9 -14) and recombinant strains were grown on ISP4 for sporulation, cultured in modified ISP4 (ISP4 containing 0.1% tryptone, and 0.05% yeast extract) for intergeneric conjugation, and fermented in 2% glycerol, 2% dextrin, 1% soy peptone, 0.3% yeast extract, 0.2% (NH 4 ) 2 SO 4 , and 0.2% CaCO 3 , pH 7.0 for metabolite production (9, 10) . When necessary, antibiotics were added at the following concentrations of ampicillin, 100 g/ml; apramycin, 50 g/ml; chloramphenicol, 25 g/ml; kanamycin, 50 g/ml; and trimethoprim, 50 g/ml for selection (15, 16) . SuperCos1 (Stratagene, La Jolla, CA) and pGEM-T and pGEM-3zf (Promega, Madison, WI) were from commercial sources. pUC19 (15) , pUZ8002 (16) , pSET152 (16) , pKC1139 (16) , pKC1218 (16) , pOJ260 (16) , pIJ790 (17) , and pIJ773 (17) were described previously. All other plasmids and strains created in this study are summarized in supplemental Table S1 .
Genetic Manipulation-Genomic DNAs from S. platensis strains were prepared according to standard protocols (16) . Plasmid DNA was prepared with Qiagen mini-prep kit (Qiagen Inc., Valencia, CA). Cosmids were prepared by the standard alkaline methods (15) . -RED-mediated PCR-targeting mutagenesis was carried out according to literature procedures (16) . The expand high fidelity PCR system (Roche Applied Science, Indianapolis, IN) was used for all PCR experiments, and PCR products were cloned into pGEM-T to confirm fidelity by sequencing and restriction enzyme digestions. Southern analysis was performed according to standard protocols (15) using the DIG system (Roche, Palo Alto, CA). DNA sequencings were performed using the BigDye Terminator v3.1 Cycle Sequencing Ready Reaction Kit (Applied Biosystems, Foster City, CA).
S. platensis protoplast preparation and transformation were carried out according to standard protocols (16) . E. coli-S. platensis intergeneric conjugation was performed by following literature procedures (16) but with three alterations: (i) S. platensis spores in 2xYT were germinated at 50°C for 10 min followed by incubation at 28°C for additional 8 -12 h to be used as recipients, (ii) E. coli ET12567/pUZ8002 was used as donors, and (iii) trimethoprim, instead of nalidixic acid, was used to kill the E. coli donors for selecting S. platensis exconjugants.
Genome Scanning and Sequence Analysis-Genome scanning was performed as previously described (18) . Briefly, chromosomal DNA from S. platensis was fragmented by sonication, and DNA fragments of 1-3 kb size were ligated into pUC19 to construct a genome sampling library (GSL). Complementary chromosomal DNA of S. platensis was partially digested with SauIIIAI, and DNA fragments between 40 and 50 kb were ligated into the BamHI site of SuperCosI to construct a cluster identification library (CIL). Overlapping CILs harboring the putative clusters were identified by probing with selected PKS genes and sequenced. Sequence analysis was carried out by the Genetics Computer Group program (Madison, WI) and BLAST. Functional assignments of the deduced gene products were based on comparisons to known PKSs, including the ATless type I PKS for leinamycin (19, 20) and the archetypical type I PKS for rapamycin (21) , and other proteins of known functions. The DNA sequence reported here has been deposited in GenBank TM under accession number GQ274953. Gene Inactivation in S. platensis by -RED-mediated PCRtargeting Mutagenesis-One open reading frame (088D-orf7 located on pBS11002 for the 088D cluster) and eight genes (mgs-orf(-1), mgsA, mgsB, mgsC, mgsD, all located on pBS11004, and mgsF, mgsH, and mgs-orf1, all located on pBS11006) for the mgs cluster were inactivated in S. platensis by following the -RED-mediated PCR-targeting mutagenesis method (17) . Thus, each of the targeted genes was replaced by the aac(3)VoriT cassette from pIJ773 via -RED-mediated PCR-targeting strategy using oligonucleotide pairs KS1-delF and KS1-delR, orf(-1)-delF and orf(-1)-delR, mgsA-delF and mgsA-delR, mgsB-delF and mgsB-delR, mgsC-delF and mgsC-delR, mgsDdelF and mgsD-delR, KS4-delF and KS4-delR, mgsH-delF and mgsH-delR, and orf1-delF and orf1-delR (supplemental Table  S2 ) to yield pBS11007, pBS11008, pBS11009, pBS11010, pBS11011, pBS11012, pBS11013, pBS11014, and pBS11015, respectively (supplemental Table S1 ). Each of the mutant constructs were confirmed by PCR using primer pairs KS1-CF and KS1-CR, orf(-1)-CF and orf(-1)-CR, mgsA-CF and mgsA-CR, mgsB-CF and mgsB-CR, mgsC-CF and mgsC-CR, mgsD-CF and mgsD-CR, KS4-CF and KS4-CR, mgsH-CF and mgsH-CR, and orf1-CF and orf1-CR, respectively (supplemental Table  S2 ). They were subsequently introduced into the S. platensis wild-type strain by intergeneric conjugation between S. platensis-E. coli ET12567/pUZ8002. Exconjugants with the aparamycin-resistant and kanamycin-sensitive phenotypes were selected as the desired double crossover mutants. Their genotypes were finally confirmed by Southern analysis using the aac(3)V gene, the targeted gene, or both as probes (supplemental Table S2 ). The correct mutant strains were named SB11006 (⌬088D-orf7), SB11007 [⌬mgs-orf(-1)], SB11008 (⌬mgsA), SB11009 (⌬mgsB), SB11010 (⌬mgsC), SB11011 (⌬mgsD), SB11012 (⌬mgsF), SB11013 (⌬mgsH), and SB11014 (⌬mgs-orf1), respectively (supplemental Table S1 ).
Complementation of ⌬mgsH Mutant SB11013 Strain-The mgsH expression plasmid pBS11019 was constructed in a pSET152-based integrative plasmid to complement the ⌬mgsH mutation in strain SB11013. First, the kanamycin resistance gene (neo) was amplified by PCR from pBS11004 with primer pair NeoSacF and NeoSacR (supplemental Table S2 ) and cloned as an SacI fragment to replace the apramycin resistance gene [aac(3)IV] in pSE152 to afford pBS11016. Second, the aac(3)IV promoter was amplified by PCR from pIJ773 with primer pairs Apr-ProF and Apr-ProR (supplemental Table S2 ), cloned into pGEM-T, and moved as an EcoRI fragment into pGEM-3Zf to yield pBS11017. Third, the mgsH gene was amplified from pBS11004 by PCR with primer pair mgsH-compF and mgsH-compR (supplemental Table S2 ), cloned into pGEM-T, and moved as an XbaI fragment into the same site of pBS11017 to afford pBS11018. Fourth, a HindIII fragment, harboring the aac(3)IV promoter and mgsH, was released from pBS11018, blunt-ended with T4-DNA polymerase, and cloned into the EcoRV site of pBS11016 to yield pBS11019. Finally, pBS11019 was introduced into SB11013 by conjugation. Exconjugants were selected on the basis of resistance to both apramycin and kanamycin and named SB11015, in which the expression of mgsH is under the control of the apramycin resistance gene promoter to complement the ⌬mgsH mutation in the SB11013 strain in trans (supplemental Table S1 ).
S. platensis Fermentation and Isolation and Analysis of iso-MGS, MGS
, and the DGNs-S. platensis fermentation and isolation and analysis of iso-MGS, MGS, and the DGNs were carried out as described previously (9, 10, 12, 13) . A two-stage fermentation process was used, with both stages utilizing the same medium. Thus, 50 l of spore suspension were inoculated into 50 ml of medium and incubated on a rotary shaker at 250 rpm, 28°C for 2 days. The resultant seed culture (2.5 ml) was then inoculated into 50 ml of fresh medium with or without the addition of XAD-16 (15%) or HP-20 (7%) resins, and incubation continued under the same condition for 4 -10 days. In the presence of XAD-16 or HP-20, iso-MGS was isolated as the major metabolite. In the absence of XAD-16 or HP-20, iso-MGS underwent rapid H 2 O-mediated, non-enzymatic ring-expansion and ring-opening rearrangement to afford MGS and the DGNs as the major metabolites (9, 10) . HPLC analysis of iso-MGS, MGS, and the DGNs were carried out on Varian HPLC system (Woburn, MA) using a Prostar 330 detector and a Prodigy ODS-2 column (150 ϫ 4.6 mm, 5 m) (9, 10). The mobile phases consisted of buffer A (15% CH 3 CN in H 2 O containing 0.1% HOAc) and buffer B (80% CH 3 CN in H 2 O containing 0.1% HOAc). The column was eluted with a linear gradient of 100% buffer A to 20% buffer A and 80% buffer B over 20 min, followed by 5 min at 20% buffer A and 80% buffer B at a flow rate of 1.0 ml/min with UV detection at 205 nm. Under these conditions, iso-MGS, MGS, and DGN A, and DGN B were eluted with retention times of 18.8, 14.6, 11.8, and 11.1 min, respectively. The identities of the metabolites were confirmed previously by MS and 1 H and 13 C NMR analyses (2-5, 9, 10).
RESULTS

Genome Scanning of S. platensis NRRL 18993 Reveals Two Putative Biosynthetic Gene Clusters Featuring AT-less Type I
PKSs-Genome scanning (18) permitted cloning and sequencing of the biosynthetic gene cluster from S. platensis for iso-MGS and its shunt metabolites MGS and the DGNs. PKS genes generated from a GSL were used as probes to identify clones containing PKS genes from the CIL. Five clones, named pBS11002, pBS11003, pBS11004, pBS11005, and pBS11006, were identified, sequenced, analyzed, and mapped to two distinct loci. The overlapping cosmids pBS11002 and pBS11003 form the biosynthetic gene cluster named 088D (supplemental Fig. S1 ). The overlapping cosmids pBS11004, pBS11005, and pBS11006 were converged to form the mgs gene cluster (Fig. 2) . Both the 088D and mgs clusters were found to contain genes encoding AT-less type I PKSs, type II acyl carrier proteins (ACPs), and amidotransferases (AMTs) likely associated with biosynthesis of glutarimide-containing polyketides (4, 22) .
Development of a Genetic System for S. platensis NRRL 18993-Introduction of either replicative plasmids such as pKC1139 and pKC1218 or integrative plasmid pSET152 into S. platensis by protoplast transformation was not successful despite extensive effort (16) . E. coli-Streptomyces intergeneric conjugation proved central to all genetic studies herein. Optimal conjugation was achieved by using (i) S. platensis spores as recipients that were prepared by prolonged heat-shock, (ii) E. coli ET12567 (pUZ8002) as donors that provided unmethylated donor DNA, and (iii) trimethoprim to eliminate E. coli from the desired S. platensis exconjugants because S. platensis is sensitive to nalidixic acid, the most commonly used antibiotic in E. coli-Streptomyces conjugation (16) . Under these conditions, the integrative plasmid pSET152 can be introduced into S. platensis with a frequency of 10
Ϫ6
, introduction of replicative plasmids such as pKC1139 and pKC1218, carrying the pSG5 and SCP2 * replicons, respectively, into S. platensis was not successful, and integration by homologous recombination was not observed for non-replicative plasmid such as pOJ260 that harbors S. platensis DNA (up to 10 kb). Finally, we resorted to the -RED-mediated PCR-targeting mutagenesis method, which makes use of the full-length insert on the cosmid to maximize
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homologous recombination frequency, for gene inactivation in S. platensis. We routinely isolated up to 30 exconjugants per plate, 30% of which were often the desired double crossover mutants.
Production and Isolation of iso-MGS, MGS, and the DGNs-We have previously established that iso-MGS
is the nascent biosynthetic product and MGS and the DGNs are shunt metabolites of iso-MGS resulting from H 2 O-mediated, non-enzymatic ring expansion and ringopening rearrangements (9, 10) . We have subsequently optimized iso-MGS production and established isolation and analytical protocols for iso-MGS, MGS, and the DGNs (9, 10). Thus, iso-MGS was the predominant metabolite if S. platensis fermentation was supplemented with hydrophobic resins such as XAD-16 or HP-20 (Fig. 3A, trace I) , whereas in the absence of the resins, MGS and the DGNs were the major products (Fig. 3B, trace I) .
The ⌬088D-orf7 Mutant SB11006 Strain Retains the Ability to Accumulate iso-MGS, MGS, and the DGNs-088D-orf7 encodes an ATless type I PKS comprised of five PKS modules (supplemental Fig. S1 and Table S3 ). Inactivation of the 088D locus was achieved by replacing the PKS module-1 of 088D-orf7 with the aac(3)IV-oriT cassette as depicted in Fig. 4A . The genotype of the resultant ⌬008D-orf7 mutant SB11006 strain was confirmed by Southern analysis using probes against both the aac(3)IV gene and a fragment of 088D-orf7 (Fig. 4B) . SB11006 was fermented under the established conditions in the presence of XAD-16 with the S. platensis wild-type strain as a positive control. HPLC analysis showed that the SB11006 mutant strain still produced iso-MGS and there was no difference in metabolite profile between the S. platensis wild-type and SB11006 mutant strains (Fig.  3A, traces I and II) .
Inactivation of mgsF Abolishes Production of iso-MGS, MGS, and the DGNs-The mgsF gene encodes an AT-less type I PKS consisting of six PKS modules ( Fig. 2 and Table  1) , and the mgs locus was next inactivated by replacing the PKS module-4 of mgsF with the aac(3)IV-oriT cassette as depicted in Fig. 4C . The resulting SB11012 mutant strain was similarly confirmed by Southern analysis (Fig. 4D) . SB11012 was fermented in the presence of Table 1 . E, EcoRI. 
SB11011 (⌬mgsD), (trace VI) SB11014 (⌬mgs-orf1). iso-MGS (ࡗ), MGS (), DGN A (F), and DGN B (छ).
XAD resin with the S. platensis wild-type strain as a positive control, and HPLC analysis revealed that SB11012 cannot produce iso-MGS (Fig. 3A, traces I and III) .
DNA Sequence Analysis of the mgs Cluster-Sequence analysis of an 84.9-kb contiguous DNA region, covered by the overlapping cosmids pBS11004, pBS11005, and pBS11006, led to the identification of 34 open reading frames (Fig. 2) . The deduced products for each of the open reading frames were aligned with homologous sequences using BLAST programs. Of these, 11 encode for putative enzymes necessary for iso-MGS production. As summarized in Table 1 , the deduced gene products include three AT-less type I PKSs (MgsEFG) that together comprise of 11 PKS modules, one discrete AT (MgsH), one type II thioesterase (TE) (MgsB), three post-PKS tailoring enzymes (MgsI, MgsJ, and MgsK), two glutarimide biosynthesis enzymes (MgsC and MgsD), and one regulatory protein (MgsA).
Determination of the mgs Gene Cluster Boundaries by Gene Inactivation-The upstream and downstream boundaries of the mgs gene were determined to be between mgs-orf(-1) and mgsA and between mgsK and mgs-orf1, respectively. These were predicted on the basis of bioinformatics analysis and confirmed Table S2 ). The resulting SB11007 [⌬mgs-orf(-1)] and SB11014 (⌬mgs-orf1) mutant strains were confirmed by Southern analysis and fermented under the established conditions in the absence of any resins with the S. platensis wild-type strain as a positive control. HPLC analysis revealed that SB11007 and SB11014 produced MGS and the DGNs with titers comparable to the S. platensis wild-type strain (Fig. 3B, traces I , II, VI) confirming that mgs-orf(-1) and mgs-orf1 play no role in iso-MGS biosynthesis ( Fig. 1 and Table 1 ). Functional Assignment of the Genes within the mgs ClustersFunctional assignment of the 11 genes within the mgs cluster was carried out on the basis of bioinformatics analysis. The predicted roles for selected genes in iso-MGS biosynthesis were further supported by gene inactivation in S. platensis.
MgsA showed high homology to PimR (67% identity), a positive regulator of pimaricin biosynthesis in S. natalensis (23) . The N terminus of MgsA showed significant homology to Streptomyces antibiotic regulatory protein regulators such as DnrI (40% identity) from the daunorubicin pathway in S. peucetius (24) and FdmR1 (23% identity) from the fredericamycin pathway in S. griseus (25) , both of which are known transcriptional activators. The N-terminal DNA-binding domain of MgsA is similar to that of the transcription factor OmpR and mgsA also features a rare TTA codon for leucine, which has been found in the regulatory genes of several other secondary metabolite biosynthetic pathways (26 -29) . Inactivation of mgsA afforded the SB11008 mutant strain, the genotype of which was confirmed by Southern analysis (supplemental Table S2 ). Fermentation of SB11008 in the absence of resin and HPLC analysis revealed that inactivation of mgsA completely abolished MGS and DGN production (Fig. 3B , tracers I and III) supporting MgsA as a transcriptional activator for the iso-MGS biosynthetic machinery.
The mgsC and mgsD genes encode a type II ACP and an AMT, respectively. MgsC shows low identity to ACPs in MgsE, MgsF, and MgsG (5-10%) or in other type I PKS extender modules such as those for rapamycin biosynthesis (11-14%), respectively. However, MgsC exhibits significant homology to LnmP (46% identity), a type II peptidyl carrier protein located in the loading module of the leinamycin hybrid nonribosomal peptide synthetase-PKS megasynthase (20, 30) . MgsD shows significant homology to well known ATP/Mg 2ϩ -dependent asparagine synthetases such as AsnB (31% identity), which convert aspartic acid into asparagine, and the conserved amino acid residues for binding of glutamine and AMP-CPP and Mg 2ϩ were also found in MgsD (31) (32) (33) . As with all inactivation mutants, both mgsC and mgsD were inactivated using the -RED-mediated PCR-targeting mutagenesis method and the resultant mutant strains SB11010 (⌬mgsC) and SB11011 (⌬mgsD) confirmed by Southern analysis (supplemental Table  S2 ). SB11010 and SB11011 were fermented in the absence of resin. HPLC analysis of the fermentation broths showed a complete abolishment of MGS and DGN production in both strains (Fig. 3B, traces I, IV, and V) . These results support their proposed role in construction of the glutarimide moiety of iso-MGS with MgsC responsible for loading malonyl CoA to the PKS machinery and MgsD responsible for amino group installation prior to ultimate glutarimide formation (Fig. 5A) .
The mgsE, mgsF, and mgsG genes encode AT-less type I PKSs, together constituting ten PKS modules, none of which contains the cognate AT domain, a hallmark feature of AT-less type I PKSs (19, 20, 22, 34 -36) . The ketoacyl synthase (KS) 
FIGURE 5. Proposed biosynthetic pathway for iso-MGS as well as MGS and the DGNs according to module and domain organization of MgsCD glutarimide biosynthesis enzymes, the MgsEFG AT-less type I PKSs and the MgsH discrete AT, and the MgsIJH post-PKS tailoring enzymes.
A, biosynthesis of glutarimide starter unit (heavy bonds denote intact incorporation from malonate) and B, overview of the iso-MGS biosynthetic machinery featuring the iso-MGS AT-less type I PKS with 8-desmethoxy-17-hydroxy-iso-MGS as the nascent intermediate en route to iso-MGS and its subsequent H 2 O-mediated, non-enzymatic ring-expansion and ring-opening rearrangements to MGS and the DGNs. The ACP domain indicated with an overlaid X is nonfunctional, black ovals denote AT-docking domains, and the domain with a question mark denotes an unknown function. Fig. S2 ) (19, 20, 22, 34 -36) . The 11 ACPs in the MgsE, MgsF, and MgsG exhibit high homology to known ACPs in "AT-less" type I PKSs but low homology to ACPs in archetypical type I PKSs. These ACPs can be grouped in a phylogenetic clade distinct from ACP domains of typical type I PKSs as those of KS domains in "AT-less" type I PKSs (34 -36). 10 of 11 ACP domains feature the conserved (D/E)S(I/L/F) motif, the Ser residue of which is post-translationally modified by covalent attachment of the 4Ј-phosphopantetheine group, a reaction absolutely required for PKS activities (37, 38) . Interestingly, module-9 of MgsF contains two ACP domains, the first of which has a mutated motif DPV with the conserved Ser substituted by a Pro residue, and hence cannot be functional in iso-MGS biosynthesis (Fig. 5B) .
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The MgsE, MgsF, and MgsG PKSs also feature six ketoreductase (KR) domains (in module-2, -4, -6, -7, -9, and -11) and five dehydratase (DH) domains (in module-2, -6, -9, -10, and -11), but completely lack any enoylreductase (ER) domain (Fig. 5B) . All KR domains are characterized with the Rossman fold and the conserved catalytic Lys, Tyr, and Ser residues (37, 39 -41) . In addition, five of them (in module-2, -4, -6, 9, and 11) have the LDD motif (but not apparent PXXXN motif) characteristic of B-type KRs. The KR domain in module-7 does not have any apparent LDD motif or PXXXN motif, and, therefore, is correlated with formation of A-type alcohol stereochemistry (39 -41) . The KR domain of module-7 is predicted to yield an -OH with an R-configuration at C-11, which is consistent with the absolute stereochemistry found in iso-MGS and its biosynthetic intermediates (Figs. 1 and 5B) . The five DH domains were found to have the conserved motif of HXXXGXXXXP characteristic of known DH domains (37) . The essential amino acids His and Pro are very well conserved except in the DH domain of module-10, casting doubt if this DH domain is functional in iso-MGS biosynthesis.
There are two methyltransferase (MT) domains in module-6 and -7 of the MgsF PKS that have good similarity to each other (45% identity) and show high identities (59 and 55%, respectively) to the MT domain in BaeR, an AT-less type I PKS involved in bacillaene biosynthesis in Bacillus amyloliquefaciens FZB 42 (42) . The MT domains contain a glycine-rich loop EXXXGXG in motif I and a negatively charged residue Asp in motif II that are highly conserved in most known S-adenosyl methionine-dependent MTs (43) .
At the C terminus of the MgsG PKS is a TE domain with low homology to other known type I TEs (less than 16% identity), but having high homology to the TE domain in RhiF (37% identity), an AT-less type I PKS involved in rhizoxin biosynthesis (44) . Accordingly, the MgsG-TE domain displays the conserved catalytic triad Ser, His, and Asp and the GXSXG motif permitting well-established critical substrate-TE interactions (45).
Three genes, mgsI, mgsJ, and mgsK, residing proximal to the downstream mgs cluster boundary encode three putative tailoring enzymes responsible for post-PKS processing of the nascent polyketide intermediate en route to iso-MGS (Fig. 5B) . The deduced gene product of mgsI displays high homology to putative oxidoreductases of bacterial origin, that of mgsJ shows high homology to MitM (54% identity), an O-methyltransferase involved in mitomycin biosynthesis from Streptomyces lavendulae NRRL 2564 (46) , and MgsK resembles the NikF P-450 hydroxylase (48% identity) involved in nikkomycin biosynthesis (47) .
Two genes, mgsB and mgsH, within the mgs cluster appear to encode putative discrete ATs. The deduced gene product of mgsB was predicted to be a didomain protein with an AT domain at its N terminus and a TE domain at its C terminus, while mgsH was predicted to encode a didomain protein comprising an AT domain at it N terminus and an oxidation (Ox) domain at its C terminus. Discrete ATs with such an AT-TE or AT-Ox didomain organization are well known for AT-less type I PKS, but the precise functions for each of these domains remain poorly characterized (19, 20, 22, 34 -36) . Thus, the MgsB-AT domain showed homology to the discrete AT domain in RhiG (52% identity) involved in rhizoxin biosynthesis (44), while the MgsB-TE domain, with a GXSXG conserved motif, resembled the TE domain in McyT (36% identity), which is involved in the biosynthesis of the hepatotoxic peptide microcystin from Planktothrix agardhii (48) . MgsH shows high homology to BacE (47% identity), an AT-Ox didomain for the AT-less type I PKS in bacillaene biosynthesis from B. amyloliquefaciens FZB 42 (42) . The AT domains of both MgsB and MgsH can be clustered in the same phylogenetic clade with known discrete ATs that act in trans with AT-less type I PKSs and were found to contain the conserved amino acids for malonyl-CoA-specific active sites (34 -36) .
The mgsB and mgsH genes were inactivated and the resultant mutant strains SB11009 (⌬mgsB) and SB11013 (⌬mgsH) confirmed by Southern analysis (supplemental Table S2 and Fig.  S3 ). SB11009 and SB11013, as well as SB11015, in which the ⌬mgsH mutation is complemented by expressing a functional copy of mgsH in trans, were fermented in the presence of XAD-16 resin with the S. platensis wild-type strain as a positive control, and their metabolite profiles were determined by HPLC analysis. Surprisingly, the SB11009 mutant strain still produced iso-MGS, albeit with a significantly reduced titer relative to the wild-type (Fig. 3A, traces I and IV) . This finding precluded MgsB as a discrete AT. In contrast, the SB11013 mutant strain completely abolished iso-MGS biosynthesis (Fig.  3A, traces I and V) , and iso-MGS production was found to be partially restored upon expression of a functional copy of mgsH in trans as exemplified by SB11015 (Fig. 3A, traces I, V, and VI) . Taken together, these results establish that MgsH is the only discrete AT for the iso-MGS biosynthetic machinery, providing malonyl CoA to all 11 PKS modules of the iso-MGS AT-less type I PKS for iso-MGS biosynthesis.
DISCUSSION
Cluster Naming Rationale-S. platensis NRRL 18993 produces an array of glutarimide-containing polyketides including the 14-membered macrolide MGS, the acyclic DGNs, and the 12-membered macrolide iso-MGS (Fig. 1) (2-5) . We have previously established that MGS and DGNs are shunt metabolites of iso-MGS in vitro thereby showing that the disclosed mgs cluster, in fact, encodes the biosynthesis of iso-MGS (9) . For the purposes of continuity with previous literature (9 -14), we continue to refer here to the cluster responsible for iso-MGS synthesis as the mgs cluster.
Identification of the iso-MGS Biosynthetic Gene Cluster-Genome scanning of S. platensis NRRL 18993 unveiled a large number of gene clusters, two of which, 088D and mgs, encoded AT-less type I PKSs, a characteristic consistent with early feeding experiments for iso-MGS biosynthesis (4, 22) . The two clusters have similar gene organizations ( Fig. 2 and supplemental  Fig. S1 ), several genes within which encode proteins with high sequence homology such as 088D-Orf4/MgsH, 088D-Orf5/ MgsC, 088D-Orf6/MgsD, 088D-Orf7/MgsEF, and 088D-Orf8/ MgsB (Table 1 and supplemental Table S3 ). Construction of SB11006 (⌬088-orf7) and SB11012 (⌬mgsF) mutant strains (Fig.  4) followed by metabolite analysis revealed that ablation of the 088D locus had no impact upon iso-MGS production, whereas inactivation of mgsF abolished iso-MGS, as well as, MGS and DGN production (Fig. 3A) . In addition, the ⌬mgsA (SB11008), ⌬mgsC (SB11010), ⌬mgsD (SB11011), and ⌬mgsH (SB11013) mutant strains were all incapable of iso-MGS, MGS, and DGN production (Fig. 3B) . Combined, these results unambiguously establish that iso-MGS biosynthesis is governed by the mgs cluster and is completely independent of the 088 cluster.
Biosynthesis of the Glutarimide Moiety-Iso-MGS, MGS, and the DGNs all share a glutarimide moiety, the biosynthesis of which remains poorly understood. Substantial insight into the construction of this moiety was revealed upon sequencing and bioinformatics analysis of the mgs cluster. MgsE, MgsF, and MgsG are all AT-less type I PKSs where MgsE contains module-2 and -3, MgsF contains module-4, -5, -6, -7, -8, and -9, and MgsG contains module-10 and -11 ( Figs. 2 and 5 ). Acting in concert with MgsE, MgsF, and MgsG are MgsC, a putative type II ACP, and MgsD, an AMT, that constitutes the loading module (i.e. module-1) to initiate iso-MGS biosynthesis, with MgsD to derive the glutarimide amine from glutamine (Fig. 5A) . We now propose that the malonyl unit on the loading module is incorporated intact (providing C-19, C-22, and C-23 of iso-MGS) by using the primary amide nitrogen as the nucleophile to afford a triketide intermediate. The latter then undergoes a decarboxylative condensation via intramolecular Michael addition to afford the glutarimide intermediate (providing C-21 and C-20 of iso-MGS) (Fig. 5A ). While this proposal is consistent with previous feeding experiments for the glutarimide moiety of iso-MGS (4), it is not clear at present how the glutarimide intermediate, tethered to the ACP of PKS module-2, is transitioned to PKS module-4 for the subsequent elongation (Fig. 5) .
Identification of MgsH as the Discrete AT for the iso-MGS AT-less Type I PKS-The iso-MGS
AT-less type I PKS completely lacks cognate AT domains and cannot be functional unless a discrete AT provides the AT activity in trans (19, 20, 22, 34 -36) . Two genes, mgsB and mgsH, were identified within the mgs cluster, each of which encodes a putative AT domain, serving as a candidate to provide the AT function to the iso-MGS AT-less type I PKS in trans (Fig. 2 and Table 1 ). The AT domains of both MgsB and MgsH were found to contain the conserved active site motif GHSLG, typical of all malonyl-specific discrete ATs found in AT-less type I PKS systems characterized to date. On this basis we initially postulated that both MgsB and MgsH could provide the needed AT activity for the iso-MGS AT-less type I PKS.
Inactivation of mgsB and mgsH, however, established MgsH as the sole discrete AT for the iso-MGS AT-less type I PKS (supplemental Table S2 and Fig. S3 ). The ⌬mgsH mutant SB11013 strain completely lost its ability to produce iso-MGS, and iso-MGS production could be partially restored upon expressing mgsH in trans (SB11015), as would be expected for a discrete AT enzyme acting in trans for an AT-less type I PKS (Fig. 3A, tracers I, V, and VI) . In contrast, the ⌬mgsB mutant SB11009 strain was still capable of producing iso-MGS, albeit at a significantly lower titer than that of the wild-type strain (Fig.  3A, traces 1 and IV) . This precluded MgsB as an AT in iso-MGS biosynthesis since inactivation of the AT would completely abolish iso-MGS production. Close examination of MgsB revealed a TE domain at its C terminus that showed significant sequence homology to type II TEs (Table 1) . Type II TEs have been proposed to play an important role in maintaining normal levels of polyketide production by removing aberrant intermediates that might otherwise block the PKS megasynthase (49 -52) . The reduced production of iso-MGS observed for the ⌬mgsB mutant SB11009 strain is reminiscent of the mutant phenotypes of type II TEs associated with polyketide biosynthetic pathways for picromycin (49) , tylosin (50), rifamycin (51) , and erythromycin (52) . Taken together, we now propose that MgsB most likely acts as a type II TE for the iso-MGS biosynthetic machinery. Homologs of both MgsH and MgsB are well known for numerous AT-less type I PKSs characterized to date, both of which have all been annotated as discrete ATs (22, 34 -36) . Our findings that MgsH is a discrete AT and MgsB is a type II TE here should now be taken into consideration in re-evaluating their roles in their respective pathways.
Post-PKS Tailoring Enzymes-The iso-MGS AT-less type I PKS affords 8-desmethoxy-17-hydroxy-iso-MGS as the nascent intermediate, which, in fact, has been previously isolated from the S. platensis wild-type strain as a minor metabolite (Fig.  5B) (10) . Minimally four steps, hydroxylation at C-8, O-methylation at HO-C-8, dehydration of the C-17 OH moiety, and enoyl reduction of the C-16/C-17 olefin, could be envisioned for converting the nascent intermediate to iso-MGS (Fig. 5B) . Three tailoring enzymes were identified with the mgs cluster, MgsI, MgsJ, and MgsK, together accounting for three of the four steps (Fig. 2) . Thus, we envision that the MgsI reductase is responsible for enoyl reduction of the C-16/C-17 olefin, the MgsK P-450 hydroxylase is responsible for C8 hydroxylation, and the MgsJ O-methyltransferase is responsible for O-methylation of the HO-C-8. The exact timing for each event is unknown at present, and also unclear is the nature of C-17 dehydration prior to enoyl reduction by MgsI (Fig. 5B) .
Model for iso-MGS, MGS, and DGN Production in S. platensis-The mgs cluster is characterized by many intriguing features, and its elucidation presents us with fundamentally new knowledge pertaining to PKS structures and mechanisms.
Most striking, the iso-MGS PKS lacks cognate AT domains in all PKS modules; the missing AT activity is provided instead by the discrete AT (MgsH) that, acting iteratively in trans, loads the malonate to all 11 modules of the iso-MGS AT-less type I PKS (Fig. 5) . The iso-MGS AT-less type I PKS thus joins the likes of the leinamycin AT-less type I PKS (experimentally validated) and other members of the rapidly growing family of AT-less type I PKSs for which fewer details are known (19, 20, 22, 34 -36) .
The iso-MGS AT-less type I PKS also lacks a number of reductive domains based on the structure of the nascent polyketide intermediate and the co-linear model for its biosynthesis (Fig. 5B) . These include two KR domains in module-8 and -10, respectively, and an ER domain in module-10. At present it is unclear how the transformations attributable to these missing domains are carried out in iso-MGS biosynthesis, although such predictive deviations are common for AT-less type I PKSs (22, 34 -36) .
The mgs cluster is characterized also by a domain that is unprecedented in PKSs (35, 37) and shows no homology to any proteins of known functions. Intriguingly, this domain resides between the docking domain and ACP in module-3 of MgsE, and it is therefore tempting to speculate that this domain may play a role in biosynthesis of the glutarimide moiety or in channeling it for subsequent elongation (Fig. 5A) .
Functional characterization of the mgs cluster provides a first look at the specifics of glutarimide biosynthesis. Though further studies are needed to elucidate the exact pathway, it is clear that MgsC, MgsD, and MgsE work together to produce an intact glutarimide intermediate that is then handed off to the ACP of module-3 for polyketide elongation by PKS module-4 to -11 of MgsF and MgsG (Fig. 5) . iso-MGS biosynthesis, proceeding in a linear fashion with the glutarimide serving as a starter unit, highlights yet another novel strategy for PKSs to expand polyketide natural product structural diversity. Findings unveiled by the iso-MGS biosynthetic machinery most likely could be translated into the biosynthesis of other glutarimidecontaining natural products. Complete characterization of the mgs cluster now provides an excellent platform to engineer novel analogs by combinatorial biosynthesis methods. Such analogs are likely to dramatically accelerate the pace at which these natural products can be developed into drugs with a host of important bioactivities.
